The AHA today urged the Centers for Medicare & Medicaid Services to suspend the pain-related questions in the Value-Based Purchasing Program while the agency works to address concerns the questions may inadvertently contribute to the opioid epidemic. The three questions are part of the Hospital Consumer Assessment of Healthcare Providers and Services. “The AHA agrees that the HCAHPS survey should inquire about pain management, that performance scores should be publicly reported, and that redesigned pain questions should eventually be reincorporated into the VBP program,” wrote Ashley Thompson, AHA senior vice president of public policy analysis and development. “However, we also want to ensure that the questions do not create pressure to prescribe opioids or other prescription painkillers or punish providers who, in their best judgment, choose not to prescribe them.”

Related News Articles

Headline
In a new "Safety Speaks" conversation, Jamie Orlikoff, president of Orlikoff & Associates, Inc. and AHA national adviser on governance and leadership,…
Headline
The Centers for Medicare & Medicaid Services July 31 updated the Overall Hospital Quality Star Ratings at its Care Compare website and Provider Data…
Headline
The AHA along with the Federation of American Hospitals, America’s Essential Hospitals and the Association of American Medical Colleges July 29 filed an amicus…
Headline
Boston Medical Center, a private, not-for-profit, equity-led academic medical center, is the winner of AHA’s 2024 Foster G. McGaw Prize for its leadership and…
Headline
WellSpan Health in York, Pa., will receive the 2024 AHA Quest for Quality Prize for its commitment to improving quality through its health equity strategic…
Headline
The Centers for Medicare & Medicaid Services July 16 released its final guidance on the Medicare Prescription Payment Plan which will begin next year. The…